Nurix CSO Gwenn Hansen sells 4,111 shares for $100,068.32

• Nurix Therapeutics Chief Scientific Officer Gwenn Hansen sold 4,111 common shares on Aug. 4.
• Sales priced at USD 23.87 and USD 24.64 per share.
• Post-transaction direct holdings totaled 117,227 common shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nurix Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001817160-26-000015), on August 05, 2026, and is solely responsible for the information contained therein.